Medable, founded in 2016, is based in the United States and operates in the Health Care, Medical Devices, Messaging, and Pharmaceutical industries. The company's slogan, "Leading the technology revolution in clinical development," encapsulates its commitment to transforming clinical trials through technology.
Medable offers a robust end-to-end cloud platform designed to streamline and enhance collaboration among sponsors, patients, providers, and CROs in clinical research. This allows for more efficient research processes, improved healthcare delivery, and enhanced precision medicine, aligning with its mission to expedite the delivery of effective therapies to patients.
The company received a significant $304.00M Series D investment on October 1, 2021, from prominent investors including Blackstone Group, GSR Ventures, Sapphire Ventures, Western Technology Investment, Tiger Global, and Blackstone Accelerates Growth. This funding underscores investor confidence in Medable's vision of accelerating pathologies and innovations in clinical development.